Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States

Published:2023-01 Issue:1 Volume:5 Page:100564
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Zhao Julie Z.,Weinhandl Eric D.,Carlson Angeline M.,St. Peter Wendy L.

Funder

Government of South Australia

Centers for Medicare and Medicaid Services

University of Minnesota

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference34 articles.

1. Predictors of new-onset kidney disease in a community-based population;Fox;JAMA,2004

2. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management;Beckman;JAMA,2002

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

4. Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups;Mahaffey;Circulation,2019

5. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Care of Diabetes and the Sacrifice of Evidence-Based Medicine and Health Equity;Journal of General Internal Medicine;2024-07-09

2. Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records;Clinical Transplantation;2024-04

3. Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications;Diabetes Care;2024-03-27

4. Paving a Path to Equity in Cardiorenal Care;Seminars in Nephrology;2024-03

5. Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes;Journal of Clinical Medicine;2024-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3